Cytisine Compared to Combination NRT in Relapsed Smokers

NCT04286295 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Feasibility

Conditions

Smoking Cessation
Coronary Artery Disease

Interventions

DRUG: Cytisine
DRUG: Nicoderm C-Q Transdermal Product
DRUG: Nicorette Lozenge Product

Sponsor

Ottawa Heart Institute Research Corporation